Objectives: To determine the effect of adding dexmedetomidine to bupivacaine for neuraxial
anesthesia. Methods: Sixty-six patients were studied between April and May 2008 in the …

Background: The prolongation of spinal anesthesia by using clonidine through the oral,
intravenous and spinal route has been known. The new α2 agonist, dexmedetomidine has …

Aims: Intravenous (IV) dexmedetomidine with excellent sedative properties has been shown
to reduce analgesic requirements during general anaesthesia. A study was conducted to …

Low-dose bupivacaine can limit the spinal block level with minimal hemodynamic effects
and yield a rapid recovery, but sometimes it may not provide adequate anesthesia for …

Background: Spinal anaesthesia is the most common approach which is used for lower limb
surgery. Dexmedetomidine is the recent drug which acts on α2-adrenergic receptors in the …

Sudheesh and Harsoor: Dexmedetomidine in anaesthesia practice when used as an
adjuvant to local anaesthetics for subarachnoid block, epidural and caudal epidural blocks …

Conclusion Intravenous dexmedetomidine, but not midazolam, prolonged spinal
bupivacaine sensory blockade. It also provided sedation and additional analgesia. Résumé …

Background: No drug, used as adjuvant to spinal bupivacaine, has yet been identified that
specifically inhibits nociception without its associated side-effects. Aims: This prospective …

Background: Alpha 2-adrenergic agonists have synergistic action with local anesthetics and
may prolong the duration of sensory, motor blockade and postoperative analgesia obtained …

Background This study aimed to evaluate clinical characteristics of epidural anesthesia
performed with 0.75% ropivacaine associated with dexmedetomidine. Methods Forty …